A review in OMICS: A Journal of Integrative Biology explores how core-shell nanoparticles could revolutionize drug delivery systems and play a key role in advancing personalized and precision medicine.
Suren A. Ramadhan, from Knowledge University in Erbil, Iraq, and Diyar S. Ali, from Knowledge University and Salahaddin University-Erbil, describe the benefits of core-shell nanoparticles, which provide effective drug encapsulation, shielding the drug from degradation and allowing for controlled release.
“By enabling targeted drug release, this controlled mechanism can help improve treatment outcomes and reduce side effects,” stated the authors.
Various materials, including polymers, lipids, and inorganic substances, can be used to create these nanoparticles, and these materials can be tailored for better drug loading, compatibility with the host organism, and specific chemical properties to suit different therapeutic needs.
“This innovation analysis highlights the emerging convergence of nanotechnology with precision/personalized medicine by unpacking the advances in drug delivery being enabled by core-shell nanoparticles,” says Vural Özdemir, MD, MSc, Ph.D., DABCP, MA, Editor-in-Chief of OMICS.
